Stericycle Stock Surges As Q2 Exceeds Expectations
Stericycle Inc (NASDAQ: SRCL) reported second-quarter revenue growth of 1.1% year-over-year to $679.8 million, +5% on an organic basis, beating the consensus of $677.14 million.
The gross margin declined by 168 bps to 38.3%. The operating income declined 31.5% Y/Y to $38.1 million, and the margin contracted by 266 bps to 5.6%.
The adjusted operating margin was 12.1%, down from 15.7% in 2Q21.
Adjusted EPS was $0.48, above the consensus of $0.47.
Adjusted EBITDA decreased by 16.4% Y/Y to $109 million, and margin contracted by 335 bps to 16%.
Stericycle's net cash used in operating activities year-to-date was $(18.4) million, compared to cash provided of $149.8 million a year ago. Free cash outflow of $(88.4) million.
The company held cash and cash equivalents of $45.9 million as of June 30, 2022.
Price Action: SRCL shares traded higher by 7.05% at $50.58 on the last check Friday.
See more from Benzinga
Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
